Your browser doesn't support javascript.
loading
Are We Ready for Expanding the Use of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Acute Myocardial Infarction?
Karakasis, Paschalis; Patoulias, Dimitrios; Giannakoulas, George; Fragakis, Nikolaos.
Affiliation
  • Karakasis P; Second Department of Cardiology, General Hospital Hippokration, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Patoulias D; Outpatient Department of Cardiometabolic Medicine, Second Department of Cardiology, General Hospital "Hippokration", Aristotle University of Thessaloniki, Thessaloniki, Greece; and.
  • Giannakoulas G; First Department of Cardiology, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Fragakis N; Second Department of Cardiology, General Hospital Hippokration, Aristotle University of Thessaloniki, Thessaloniki, Greece.
J Cardiovasc Pharmacol ; 84(1): 26-28, 2024 Jul 01.
Article in En | MEDLINE | ID: mdl-38968566
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sodium-Glucose Transporter 2 Inhibitors / Myocardial Infarction Limits: Humans Language: En Journal: J Cardiovasc Pharmacol / J. cardiovasc. pharmacol / Journal of cardiovascular pharmacology Year: 2024 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sodium-Glucose Transporter 2 Inhibitors / Myocardial Infarction Limits: Humans Language: En Journal: J Cardiovasc Pharmacol / J. cardiovasc. pharmacol / Journal of cardiovascular pharmacology Year: 2024 Document type: Article